Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1R11P2 is a processed pseudogene in the human genome similar in sequence to functional protein phosphatase 1 regulatory inhibitor subunit 11 (PPP1R11/I3). Pseudogenes are typically nonfunctional DNA segments, having lost the ability to encode a functional protein due to inactivating mutations such as frameshifts or premature stop codons[4][5][3]. PPP1R11P2 is not known to have any biological activity or protein product in humans, nor is it established as a therapeutic or diagnostic target. Like other pseudogenes, it may be weakly transcribed but does not produce a functional protein. There is no evidence for its involvement in disease, drug interaction, or use as a biomarker[3][4][5]. Key Notes: - The “pseudogene” status indicates loss of protein-coding function and lack of known physiological or pathological role[4][5]. - It does not belong to any major druggable molecular family (such as receptor, enzyme, ion channel, transporter). - There is no current evidence linking PPP1R11P2 to therapeutic targeting, clinical relevance, or safety considerations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory inhibitor subunit 11 pseudogene 2 (PPP1R11P2).